Yiling Pharmaceutical (002603.SZ) announced that Lianhua Qingwen capsules (granules) have been added to the “Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos” (Trial Version II) as the fourth traditional Chinese medicine to treat COVID-19 pneumonia in Laos. Lianhua Qingwen Listed in the Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos. (PRNewsfoto/Shijiazhuang Yiling Pharmaceuti) Based on its efficacy […]
(ECNS) — Recent research shows that traditional Chinese medicine Lianhua Qingwen can significantly inhibit replication of the novel coronavirus in cells, which effectively contains COVID-19 infection, Beijing News reported. The results showed that it could significantly inhibit the replication of SARS-CoV-2 in Vero E6 cells and induce inflammatory factors such as TNF-α, IL-6, CCL2/MCP-1 and […]